HDII (Hypertension Diagnostics) Current Accrued Expense: $0.86 Mil (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Current Accrued Expense?

Hypertension Diagnostics HDII -99.00% Current Accrued Expense is $0.86 Mil as of Sep. 2019.

Hypertension Diagnostics's Current Accrued Expense for the quarter that ended in Sep. 2019 was $0.86 Mil.

Hypertension Diagnostics's quarterly Current Accrued Expense stayed the same from Mar. 2019 ($0.86 Mil) to Jun. 2019 ($0.86 Mil) and stayed the same from Jun. 2019 ($0.86 Mil) to Sep. 2019 ($0.86 Mil).

Hypertension Diagnostics's annual Current Accrued Expense increased from Dec. 2016 ($1.03 Mil) to Dec. 2017 ($1.23 Mil) but then declined from Dec. 2017 ($1.23 Mil) to Dec. 2018 ($0.86 Mil).

Hypertension Diagnostics Current Accrued Expense Related Terms

Hypertension Diagnostics Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Current Accrued Expense Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.28 1.03 1.23 0.86

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 0.86 0.86 0.86 0.86

Hypertension Diagnostics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.86 Mil mean?
Hypertension Diagnostics (HDII) has a Current Accrued Expense of $0.86 Mil as of Sep. 2019. Current Accrued Expense records the total amount of accrued expenses. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Current Accrued Expense too high?
Hypertension Diagnostics' current Current Accrued Expense is $0.86 Mil.
How does Hypertension Diagnostics' Current Accrued Expense compare to ESTRF and OCLN?
Hypertension Diagnostics' Current Accrued Expense of $0.86 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Diversified Financial Services company?
A good Current Accrued Expense depends on the Diversified Financial Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Hypertension Diagnostics and its competitors. Hypertension Diagnostics's current Current Accrued Expense is $0.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Current Accrued Expense of $0.86 Mil. The current Current Accrued Expense is $0.86 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Current Accrued Expense is $0.86 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.